RecruitingNCT05482269

Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography

Prediction of Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography


Sponsor

Shengjing Hospital

Enrollment

2,000 participants

Start Date

Jan 1, 2011

Study Type

OBSERVATIONAL

Conditions

Summary

The investigators aim to build a predictive tool for Adverse Outcome of Acute Pulmonary Embolism by Artificial Intelligence System Based on CT Pulmonary Angiography.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses artificial intelligence to analyze CT scans of the lungs (CT pulmonary angiography) in patients diagnosed with a pulmonary embolism (a blood clot in the lungs). The goal is to see if AI can better predict who will have serious complications. You may be eligible if: - You are 18 years or older - You have been diagnosed with pulmonary embolism based on a CT lung scan You may NOT be eligible if: - You are pregnant - You received clot-busting treatment before hospital admission - Key test data (CT measurements, heart ultrasound, cardiac enzymes, or BNP levels) is missing Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERno intervention

no intervention


Locations(1)

Shengjing Hospital

Shenyang, Liaoning, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05482269


Related Trials